James N'Dow talks to ecancer at EAPM 2017 in Belfast.

He talks about the role of guidelines in personalised medicine, and how these are not always effectively implemented.

He encourages that before we push the boundaries too much, we should ensure that our current knowledge is implemented in the most effective way possible.

He ends by explaining how positive the benefits could be if we implemented personalised medicine guidelines effectively.